Status:
RECRUITING
Safe and Fast Radial Hemostasis Using Synergistic Strategies: SAFE & FAST Trial
Lead Sponsor:
Regional Hospital of Scranton
Conditions:
Cardiovascular Diseases
Bleeding
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The Safe and Fast Radial Hemostasis using Synergistic Strategies (SAFE \& FAST) trial is an interventional study aimed at reducing the incidence of radial artery occlusion (RAO) rebound bleeding, ...
Detailed Description
Patients referred for diagnostic trans-radial cardiac catheterization who meet the inclusion criteria will be randomized into two groups. Group 1 will receive a standard heparin dose (50 U/Kg) with a ...
Eligibility Criteria
Inclusion
- Patients referred for diagnostic transradial cardiac catheterization
- Age ≥ 18 years
- Ability to provide written informed consent
Exclusion
- Absence of written informed consent
- Patients on long-term systemic anticoagulation therapy for a different indication
- Patients requiring a heparin dose of greater than 50 units per kilogram before, during, or after the procedure for any reason.
- Patients requiring greater than 6 French catheter access
Key Trial Info
Start Date :
August 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 15 2026
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT06549842
Start Date
August 15 2024
End Date
August 15 2026
Last Update
August 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Regional Hospital of Scranton
Scranton, Pennsylvania, United States, 18510